Dana Pizzuti - Sep 30, 2022 Form 3 Insider Report for Crinetics Pharmaceuticals, Inc. (CRNX)

Role: Chief Development Officer
Signature: /s/ Marc Wilson, as attorney-in-fact
Stock symbol: CRNX
Transactions as of: Sep 30, 2022
Transactions value $: $0
Form type: 3
Date filed: 10/11/2022, 04:30 PM
Next filing: Oct 11, 2022

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power-of-Attorney